Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

A Phase II Study of Oral Panobinostat (LBH589) for Chronic Phase Chronic Myeloid Leukemia (CML) with Resistance to ≥2 BCR-ABL Tyrosine Kinase Inhibitors

Andrey Zaritskey, Giuliana Alimena, Lech Konopka, Jila Shamsazar, Priscille M. Bourquelot, Muhammad Jalaluddin, Martha Li, Anna Turkina, Gert J. Ossenkoppele, Stuart L. Goldberg, Bayard Powell

Blood (2008) 112 (11): 4254.

https://doi.org/10.1182/blood.V112.11.4254.4254

Published: 2008

Journal Articles

Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Cladribine

Blood (2008) 112 (11): 4179.

https://doi.org/10.1182/blood.V112.11.4179.4179

Published: 2008

Journal Articles

Randomized Comparison of Cladribine Plus Cyclophosphamide with Fludarabine Plus Cyclophosphamde in Untreated Patients with Chronic Lymphocytic Leukemia: Report of the Polish Adult Leukemia Group (PALG-CLL3).

Blood (2008) 112 (11): 2103.

https://doi.org/10.1182/blood.V112.11.2103.2103

Published: 2008

Journal Articles

Crosslineage T-Cell Receptor Genes Rearrangements and Active Receptor Editing in B-Cell Acute Lymphoblastic Leukemia.

Hanna Makuch-Lasica, Miroslaw Majewski, MD, Grazyna Nowak, Iwona Kania, Monika Lewandowska, Lech Konopka, MD, PhD, Krzysztof Warzocha, MD, PhD

Blood (2007) 110 (11): 4259.

https://doi.org/10.1182/blood.V110.11.4259.4259

Published: 2007

Journal Articles

Minimal Residual Disease Status Is the Most Important Preditive Factor in Adults with Acute Lymphoblastic Leukemia. Prospective, Multicenter PALG 4-2002 MRD Study.

Jerzy Holowiecki, Malgorzata Krawczyk-Kulis, Sebastian Giebel, Krystyna Jagoda, Beata Stella-Holowiecka, Beata Jakubas, Monika Paluszewska, Ilona Seferynska, Anna Czyz, Wlodzimierz Mendrek, Aleksander Skotnicki, Wieslaw W. Jedrzejczak, Krzysztof Warzocha, Lech Konopka, Andrzej Hellmann

Blood (2007) 110 (11): 2821.

https://doi.org/10.1182/blood.V110.11.2821.2821

Published: 2007

Journal Articles

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial

Blood (2007) 109 (9): 3672–3675.

https://doi.org/10.1182/blood-2006-08-042929

Published: 2007

Journal Articles

Randomized Comparison of Cladribine Plus Cyclophsophamide with Fludarabine Plus Cyclophosphamide in Progressive Chronic Lymphocytic Leukemia: An Updated Report of Prospective PALG-CLL3 Study.

Blood (2006) 108 (11): 2826.

https://doi.org/10.1182/blood.V108.11.2826.2826

Published: 2006

Journal Articles

Cladribine in Weekly Versus Daily Schedule for Untreated Active Hairy Cell Leukemia: Final Report of Polish Adult Leukemia Group (PALG) Prospective, Randomized, Multicenter Trial.

Blood (2006) 108 (11): 2485.

https://doi.org/10.1182/blood.V108.11.2485.2485

Published: 2006

Journal Articles

Improved Survival in Acute Myeloid Leukaemia Patients Aged over 40 Given Cladribine in Combination with Standard Remission Induction (DA 3+7) and Consolidation Treatment (HD AraC). Seven Year Follow-Up of Prospective, Cooperative PALG Study.

Jerzy Holowiecki, Sebastian Grosicki, MD, Andrzej Hellmann, Aleksander Skotnicki, Tadeusz Robak, Wieslaw W. Jedrzejczak, Lech Konopka, Kazimierz Kuliczkowski, Slawomira Kyrcz-Krzemien, Beata Stella-Holowiecka, MD

Blood (2006) 108 (11): 2003.

https://doi.org/10.1182/blood.V108.11.2003.2003

Published: 2006

Journal Articles

Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2)

Blood (2006) 108 (2): 473–479.

https://doi.org/10.1182/blood-2005-12-4828

Published: 2006

Journal Articles

Complementary Diagnostic and Prognostic Value of Parallel Karyotyping and Molecular Diagnostics in Patients with Acute Leukemias.

Anna Ejduk, MD, Miroslaw Majewski, MD, Iwona Solarska, Hanna Makuch-Lasica, Iwona Kania, Grazyna Nowak, Ilona Seferynska, MD, PhD, Lech Konopka, MD, PhD, Krzysztof Warzocha, MD, PhD

Blood (2005) 106 (11): 4527.

https://doi.org/10.1182/blood.V106.11.4527.4527

Published: 2005

Journal Articles

Fludarabine, Mitoxantrone and Dexametasone in the Treatment of Relapsed and Refractory Low-Grade Non-Hodgkin Lymphoma.

Joanna Sawczuk-Chabin, MD, Ewa Kalinka, MD, PhD, Piotr Centkowski, MD, Katarzyna Budziszewska, MD, PhD, Bernadeta Ceglarek, MD, PhD, Jacek Najda, MD, PhD, Maria Blasinska-Morawiec, MD, PhD, Kazimierz Sulek, MD, PhD, Jerzy Holowiecki, MD, PhD, Lech Konopka, MD, PhD, Krzysztof Warzocha, MD, PhD, for Polish Lymphoma Research Group

Blood (2005) 106 (11): 4738.

https://doi.org/10.1182/blood.V106.11.4738.4738

Published: 2005

Journal Articles

Randomized Comparison of Cladribine Containing Regimens and COP in Previously Untreated Patients with Small Lymphocytic, Marginal Zone and Follicular Lymphoma.

Ewa Kalinka, MD, Jaroslaw Wajs, MD, Kazimierz Sulek, Tadeusz Robak, Maria Blasinska-Morawiec, Joanna Sawczuk-Chabin, MD, Bernadetta Ceglarek, MD, Lech Konopka, Piotr Centkowski, MD, Ilona Seferynska, MD, Krzysztof Warzocha

Blood (2005) 106 (11): 4739.

https://doi.org/10.1182/blood.V106.11.4739.4739

Published: 2005

Journal Articles

Randomized Comparison of Cladribine with Cyclophosphamide and Fludarabine with Cyclophosphamide in Previously Untreated Progressive and Symptomatic Chronic Lymphocytic Leukemia: The Interim Analysis of PALG CLL3 Trial.

Blood (2005) 106 (11): 2121.

https://doi.org/10.1182/blood.V106.11.2121.2121

Published: 2005

Journal Articles

The Effect of Subsequent Therapies in the Patients with Chronic Lymphocytic Leukemia Previously Treated with Cladribine and Prednisone or Chlorambucil and Prednisone in Randomized Studies.

Tadeusz Robak, Jerzy Z. Blonski, Marek Kasznicki, Joanna Gora-Tybor, Anna Dmoszynska, Maria Wojtaszko, Aleksander Skotnicki, Wieslaw Nowak, Andrzej Hellmann, Krzysztof Lewandowski, Barbara Zdziarska, Lech Konopka, Bernadeta Ceglarek, Jadwiga Dwilewicz-Trojaczek, Piotr Boguradzki, Kazimierz Kuliczkowski, Kazimierz Sulek, Krzysztof Warzocha

Blood (2004) 104 (11): 4819.

https://doi.org/10.1182/blood.V104.11.4819.4819

Published: 2004

Journal Articles

Time-Sequenced G-CSF (Lenograstim) for the Treatment of Adult Acute Lymphoblastic Leukemia - Seven Year Follow-Up of the Polish Adult Leukemia Group 4–96 Study.

Sebastian Giebel, MD, Jerzy Holowiecki, Malgorzata Krawczyk-Kulis, MD, Slawomira Kyrcz-Krzemien, MD, Andrzej Hellmann, Anna Dmoszynska, Monika Paluszewska, MD, Tadeusz Robak, Lech Konopka, Ilona Seferynska, MD, Aleksander Skotnicki, Wojciech Baran, MD, Maria Adamczyk-Cioch, MD, Agata Wrzesien-Kus, MD, Krystyna Jagoda, PhD

Blood (2004) 104 (11): 2733.

https://doi.org/10.1182/blood.V104.11.2733.2733

Published: 2004

Journal Articles

Addition of Cladribine to the Standard AML Treatment Improves Long-Term Outcome in High Tumor Burden and Older Than 40 Years Acute Myeloid Leukemia Patients. Five-Year Follow-Up of the Polish Adult Leukemia Group (PALG 1999 DAC vs. DA Study).

Jerzy Holowiecki, Sebastian Grosicki, MD, Tadeusz Robak, Slawomira Krzemien, MD, Sebastian Giebel, MD, Andrzej Hellmann, Aleksander Skotnicki, Wieslaw W. Jedrzejczak, Lech Konopka, Kazimierz Kuliczkowski, Barbara Zdziarska, MD, Anna Dmoszynska

Blood (2004) 104 (11): 1795.

https://doi.org/10.1182/blood.V104.11.1795.1795

Published: 2004

Journal Articles

Cladribine Alone or in Combination with Cyclophosphamide or Cyclophosphamide and Mitoxantrone as First Line Treatment in Chronic Lymphocytic Leukemia: An Early Report of Prospective Randomized Study.

Tadeusz Robak, MD, PhD, Jerzy Z. Blonski, Joanna Gora-Tybor, Marek Kasznicki, Jadwiga Dwilewicz-Trojaczek, Agnieszka Tomaszewska, Lech Konopka, Bernadeta Ceglarek, Janusz Kloczko, Jaroslaw Sokolowski, Anna Dmoszynska, Malgorzata Kowal, Krystyna Zawilska, Beata Stella-Holowiecka, Kazimierz Sulek, Kazimierz Kuliczkowski, Krzysztof Warzocha, Malgorzata Calbecka, Aleksander Skotnicki

Blood (2004) 104 (11): 337.

https://doi.org/10.1182/blood.V104.11.337.337

Published: 2004

Journal Articles

Randomized Comparison of Weekly Administration and Daily Courses of Cladribine in Patients with Hairy Cell Leukemia - Updated Results.

Tadeusz Robak, Marek Kasznicki, Joanna Gora-Tybor, Jadwiga Dwilewicz-Trojaczek, Anna Dmoszynska, Maria Wojtaszko, Barbara Zdziarska, Malgorzata Calbecka, Andrzej Hellmann, Beata Stella-Holowiecka, Kazimierz Sulek, Aleksander Skotnicki, Krystyna Zawilska, Janusz Kloczko, Krzysztof Warzocha, Lech Konopka

Blood (2004) 104 (11): 3478.

https://doi.org/10.1182/blood.V104.11.3478.3478

Published: 2004

Journal Articles

Randomized Multicenter Trial of Cladribine Alone (C) or in Combination with Cyclophosphamide (CC), and COP in Previously Untreated Low Grade B-Cell Non-Hodgkin Lymphoma Patients: The First Interim Analysis.

Blood (2004) 104 (11): 3305.

https://doi.org/10.1182/blood.V104.11.3305.3305

Published: 2004

NARROW

A Phase II Study of Oral Panobinostat (LBH589) for Chronic Phase Chronic Myeloid Leukemia (CML) with Resistance to ≥2 BCR-ABL Tyrosine Kinase Inhibitors

Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Cladribine

Randomized Comparison of Cladribine Plus Cyclophosphamide with Fludarabine Plus Cyclophosphamde in Untreated Patients with Chronic Lymphocytic Leukemia: Report of the Polish Adult Leukemia Group (PALG-CLL3).

Crosslineage T-Cell Receptor Genes Rearrangements and Active Receptor Editing in B-Cell Acute Lymphoblastic Leukemia.

Minimal Residual Disease Status Is the Most Important Preditive Factor in Adults with Acute Lymphoblastic Leukemia. Prospective, Multicenter PALG 4-2002 MRD Study.

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial

Randomized Comparison of Cladribine Plus Cyclophsophamide with Fludarabine Plus Cyclophosphamide in Progressive Chronic Lymphocytic Leukemia: An Updated Report of Prospective PALG-CLL3 Study.

Cladribine in Weekly Versus Daily Schedule for Untreated Active Hairy Cell Leukemia: Final Report of Polish Adult Leukemia Group (PALG) Prospective, Randomized, Multicenter Trial.

Improved Survival in Acute Myeloid Leukaemia Patients Aged over 40 Given Cladribine in Combination with Standard Remission Induction (DA 3+7) and Consolidation Treatment (HD AraC). Seven Year Follow-Up of Prospective, Cooperative PALG Study.

Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2)

Complementary Diagnostic and Prognostic Value of Parallel Karyotyping and Molecular Diagnostics in Patients with Acute Leukemias.

Fludarabine, Mitoxantrone and Dexametasone in the Treatment of Relapsed and Refractory Low-Grade Non-Hodgkin Lymphoma.

Randomized Comparison of Cladribine Containing Regimens and COP in Previously Untreated Patients with Small Lymphocytic, Marginal Zone and Follicular Lymphoma.

Randomized Comparison of Cladribine with Cyclophosphamide and Fludarabine with Cyclophosphamide in Previously Untreated Progressive and Symptomatic Chronic Lymphocytic Leukemia: The Interim Analysis of PALG CLL3 Trial.

The Effect of Subsequent Therapies in the Patients with Chronic Lymphocytic Leukemia Previously Treated with Cladribine and Prednisone or Chlorambucil and Prednisone in Randomized Studies.

Time-Sequenced G-CSF (Lenograstim) for the Treatment of Adult Acute Lymphoblastic Leukemia - Seven Year Follow-Up of the Polish Adult Leukemia Group 4–96 Study.

Addition of Cladribine to the Standard AML Treatment Improves Long-Term Outcome in High Tumor Burden and Older Than 40 Years Acute Myeloid Leukemia Patients. Five-Year Follow-Up of the Polish Adult Leukemia Group (PALG 1999 DAC vs. DA Study).

Cladribine Alone or in Combination with Cyclophosphamide or Cyclophosphamide and Mitoxantrone as First Line Treatment in Chronic Lymphocytic Leukemia: An Early Report of Prospective Randomized Study.

Randomized Comparison of Weekly Administration and Daily Courses of Cladribine in Patients with Hairy Cell Leukemia - Updated Results.

Randomized Multicenter Trial of Cladribine Alone (C) or in Combination with Cyclophosphamide (CC), and COP in Previously Untreated Low Grade B-Cell Non-Hodgkin Lymphoma Patients: The First Interim Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only